CDSCO panel rejects Sanofi clinical study report on Hexavalent vaccine Dr. Divya Colin24 Sept 2022 6:00 PM ISTNew Delhi: Citing the clinical study report as not acceptable as presented, the Subject Expert Committee functional under the Central Drug Standard...
Conduct Phase II CT : CDSCO panel opines Zydus Pharma over Hepatitis E Vaccine Dr. Divya Colin14 Sept 2022 6:00 PM ISTNew Delhi: The Subject Expert Committee(SEC) functional under the Central Drug Standard Control Organization(CDSCO) has opined the pharma major Zydus...
Justify protocol amendments in detail: CDSCO Panel tells Eli Lilly on Trail of Imlunestrant Dr. Divya Colin23 Aug 2022 6:00 PM ISTNew Delhi: In response to the proposed protocol amendment for Eli Lilly's anticancer drug LY348-4356 (Imlunestrant), the Subject Expert Committee...
CDSCO approves AstraZeneca Anticancer Drug Trastuzumab Deruxtecan Protocol Amendment Dr. Divya Colin21 Aug 2022 2:00 PM ISTNew Delhi: Based on the justification provided by the pharma major AstraZeneca, the Subject Expert Committee(SEC) functional under Central Drug...
Cipla Secure CDSCO Panel Nod To Study Rizatriptan Benzoate Orally Disintegrating Tablet Dr. Divya Colin3 Aug 2022 6:00 PM ISTNew Delhi: Granting approval to conduct bioequivalence (BE) study of Rizatriptan Benzoate Orally Disintegrating Tablets 5mg, the Subject Expert...
Zydus Life Desidustat gets CDSCO panel nod to treat Anaemia in Kidney Patients Dr. Divya Colin27 July 2022 6:00 PM ISTNew Delhi: In a significant development, Zydus Life has received approval from the Subject Expert Committee (SEC) functional under the Central Drug...
AstraZeneca Olaparib gets CDSCO Panel okay for BRCA mutated HER2 negative breast cancer Dr. Divya Colin23 July 2022 6:00 PM ISTNew Delhi: Based on the scientific data provided by the drug maker AstraZeneca, the Subject Expert Committee (SEC) functional under Central Drug...
Akum Pharmaceutical gets CDSCO Nod to study GERD.FDC drug Dr. Divya Colin17 July 2022 11:15 AM ISTNew Delhi: Drug major, Akum Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Synokem gets CDSCO Panel nod to manufacture and market FDC Nortriptyline,Gabapentin Susmita Roy7 July 2022 6:30 PM ISTNew Delhi: Pharmaceutical major, Synokem Pharmaceuticals has got the go ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard...
Add Haloperidol linked cogwheel rigidity in package insert: CDSCO Panel Susmita Roy3 July 2022 11:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has recommended that CDSCO...
Macleod Pharma gets CDSCO panel conditional nod to study FDC Sitagliptin, Metformin, Glimepiride Susmita Roy28 March 2022 7:02 PM ISTNew Delhi: Pharmaceutical major, Macleods Pharmaceuticals has got the go-head from the Subject Expert Committee (SEC) of the Central Drug Standard...
Synokem gets CDSCO panel nod to market FDC Nortriptyline, Pregabalin Dr. Divya Colin19 March 2022 2:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted permission to drug...
